Balancing hERG Affinity and Absorption in the Discovery of AZD5672 (I), an Orally Active CCR5 Antagonist for the Treatment of Rheumatoid Arthritis.John G. CummingChemInform（2012）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
